JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heikinheimo, K.
Right arrow Articles by Knuutila, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikinheimo, K.
Right arrow Articles by Knuutila, S.
J Dent Res 81(8): 525-530, 2002
© 2002 International and American Associations for Dental Research


RESEARCH REPORT
Biological

Gene Expression Profiling of Ameloblastoma and Human Tooth Germ by Means of a cDNA Microarray

K. Heikinheimo1,4,*, K.J. Jee2,*, T. Niini2, Y. Aalto2, R.-P. Happonen1, I. Leivo3, and S. Knuutila2

1 Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, FIN-20520 Turku, Finland;
2 Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, FIN-00014 University of Helsinki, Finland; and
3 Haartman Institute, Department of Pathology, FIN-00014 University of Helsinki, Finland;

4 corresponding author, heikinhe{at}netlife.fi


   ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The molecular and genetic characteristics of ameloblastoma are still poorly understood. We analyzed gene expression in fresh-frozen ameloblastomas and human fetal tooth germs, using a cDNA microarray. Thirty-four genes exhibited significant changes in expression levels in the ameloblastoma. Eleven genes were overexpressed more than three-fold, and 23 genes were underexpressed to below 0.4 of the control level. The oncogene FOS was the most overexpressed gene (from eight- to 14-fold), followed by tumor-necrosis-factor-receptor 1 (TNFRSF1A). Genes for sonic hedgehog (SHH), TNF-receptor-associated-factor 3 (TRAF3), rhoGTP-ase-activating protein 4 (ARHGAP4), deleted in colorectal carcinoma (DCC), cadherins 12 and 13 (CDH12 and 13), teratocarcinoma-derived growth-factor-1 (TDGF1), and transforming growth-factor-ß1 (TGFB1) were underexpressed in all tumors. In selected genes, a comparison between cDNA microarray and real-time RT-PCR confirmed similar relative gene expression changes. The gene expression profile identifies candidate genes that may be involved in the origination of ameloblastoma and several genes previously unidentified in relation to human tooth development.

KEY WORDS: gene expression • cDNA • microarray • odontogenic tumor • RT-PCR • tooth germ.


   INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In recent years, many genes involved in tooth development have been identified, providing a new basis for studies in oral pathology (see http://bite-it.helsinki.fi/; Nieminen et al., 1998). Tooth patterning requires such genes as PAX9, BARX1, LEF1, DLX1, DLX2, MSX1, and MSX2. Important genes involved in the initiation of tooth development, morphogenesis, and cytodifferentiation include, e.g., sonic hedgehog (SHH), patched (PTCH), WNT, activin ßA, bone morphogenetic proteins 2 and 4 (BMP2 and BMP4), and several members of the fibroblast-growth-factor (FGF) family (reviewed in Jernvall and Thesleff, 2000).

Ameloblastoma is believed to arise from epithelial cells of the developing tooth, including cells of the dental lamina and enamel organ (reviewed in Melrose, 1999). The differentiation level of ameloblastoma cells remains at the cap/bell stage of tooth development. Follow-up and cell-proliferation studies of ameloblastoma confirm its slow growth rate (Jääskeläinen et al., 2002). Other clinical characteristics include preference for the molar area of the mandible, an infiltrative growth pattern, and a substantial tendency for recurrence without potential to metastasize (Vickers and Gorlin, 1970; Kramer et al., 1992). Previous gene expression studies have shown both similarities and differences with the developing human tooth (Heikinheimo, 1993). However, genetic changes in ameloblastoma are as yet poorly understood (Jääskeläinen et al., 2002).

The cDNA microarray is a powerful tool in the analysis and classification of human tumors (Duggan et al., 1999; Ross et al., 2000; Todd and Wong, 2002). We compared gene expression patterns in ameloblastoma and cap/bell-stage human tooth germs in cDNA microarray. The aims of our study were to characterize the gene expression profile of ameloblastoma, and to identify candidate genes that may be involved in the origination and progression of this tumor.


   MATERIALS & METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Fetal Teeth
Twenty deciduous tooth germs (first and second incisors, canines, first and second molars) at cap and bell stages were dissected from human fetal mandibles [16th to 18th gestational weeks, (gwh)], snap-frozen in liquid nitrogen, and stored at -70°C until use. The Institutional Review Board of the Department of Obstetrics and Gynecology, University of Helsinki, Finland, had approved the study.

Tumors
Eight fresh ameloblastoma specimens (3 follicular, 4 plexiform, and 1 of the acanthomatous type) were obtained during surgery in the Department of Oral Diseases, Turku University Central Hospital, Turku, Finland, from six men and one woman (age range from 18 to 73 yrs, mean 51 yrs). The specimens were snap-frozen in liquid nitrogen and stored at -70°C. Five tumors were primary and 3 were recurrent ameloblastomas of the mandible. The Ethical Committee of the Medical Faculty, University of Turku, Finland, had approved the study.

RNA Isolation
Total RNA was isolated from fresh-frozen tissues with use of the RNeasy Total RNA kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s instructions. To remove genomic DNA contamination, we treated RNA with RNase-free DNase 1 (Clontech Laboratories Inc., Palo Alto, CA, USA). The quality and integrity of the RNA were checked by spectrophotometry and agarose-gel electrophoresis.

cDNA Probe Labeling and Hybridization
A single-pass reverse-transcription reaction was used for preparation of labeled cDNA from total RNA, with the use of SuperScript reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD, USA). 33P-dATP was used as a labeled nucleotide according to the manufacturer’s recommendations (www.clontech.com). Atlas Human Cancer cDNA Expression Array Filters containing 588 cancer-related human cDNA fragments were purchased from Clontech Laboratories Inc. Pre-hybridization, hybridization, and post-hybridization washes were performed according to Clontech instructions. The membranes were then exposed to Fuji BAS-MS image plates (Fuji, Nakanuma, Japan), with an intensifying screen, at room temperature for 4 days. For repeated use, membranes were stripped by being boiled in a 0.5% SDS (sodium dodecyl sulphate) solution and scanned for residual hybridization.

The hybridization experiments were repeated for 3 of 9 samples (normal control tissue and 2 tumors) with the use of newly synthesized probes from original total RNA under the conditions described above.

Image Analysis
The array image plates (Fuji) were scanned by means of a BAS-2500, Fuji Bio-Imaging Analyzer (Fuji). Images obtained (in TIFF format) were imported for examination with Atlas Image 1.5 analysis software (Clontech). We compared the reference image with tumor images using global normalization, subtracting the average of the intensity differences of the genes in one array from each intensity difference value, thus standardizing the sample average in all arrays to zero. Genes exhibiting intensity ratios above 3 or less than 0.4 in 5 or more samples were classed as differentially expressed. We chose these limits to improve the selectivity of gene identification in our array experiments from less than 1% obtained with the software using a ratio of 2.0 for overexpression and 0.5 for underexpression. All differentially expressed spots on filters were also confirmed visually.

Statistical Analyses Relating to Confirmation of Gene Expression
XY scatterplots were used in parallel with global normalization. Preparation of scatterplots is a powerful method of analyzing gene expression levels in two independent array experiments. In a scatterplot, the coordinates of each dot are the gene expression values obtained in each experiment. Regression lines (y = ax + b) were drawn and R2 values derived with the use of Microsoft Excel 2.0. R2 is the Pearson correlation coefficient of the least-squares regression line. The standard deviation of mean distance between points and the least-squares regression line was calculated in Microsoft Excel 2.0. An area bounded by lines representing the standard deviation multiplied by 1.96 on both sides of the least-squares regression line was drawn on the XY scatterplot to define a 95% confidence interval. Genes outside this area were classed as differentially expressed.

Quantitative Real-time RT-PCR
To obtain comparative information on gene expression profile, we performed real-time reverse-transcription/polymerase chain-reaction (RT-PCR) on the same tumor-derived RNA samples. Primers were designed and prepared for 3 genes overexpressed (FOS, COL8A, and TNFRSF1A) and for 3 genes underexpressed (CDH11, SHH, and TGFB) in the microarray by TIB Molbiol (Berlin, Germany) (Table 1Go). A total of 500 ng RNA from each tumor studied and normal control tissue was reverse-transcribed into cDNA with the use of an oligo-p(dT)6 primer from the 1st Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche Diagnostics Corp., Indianapolis, IN, USA). PCR reactions were performed simultaneously for all tumor samples to minimize the effect of variation in amount and quality of the cDNA among samples. The real-time RT-PCR was performed with the use of a LightCycler rapid thermal cycler system (Roche Diagnostics GmbH, Mannheim, Germany). The reaction volume was 10 µL containing 1 µL "Hot Start" reaction mixture from the LightCycler-FastStart DNA Master SYBR Green I kit (Roche Diagnostics GmbH), 2.5 mM MgCl2, 0.5 mM of each primer, and 1 µL of diluted cDNA (1:10). Initial denaturation was carried out at 95°C for 7 min, with denaturation at 95°C for 15 sec and annealing at 60-65°C for 5 sec, followed by 48 cycles of elongation at 72°C for 10 sec. To verify the amplification specificity, we performed melting curve analyses using an initial denaturation at 95°C for 10 sec, followed by 20 sec at 55°C, and then heated the samples at 95°C at a slow rate of 0.1°C/sec with continuous fluorescence detection. Each patient sample was run in parallel with the control normal tissue as well as a negative control. In addition, we obtained standard curves to calculate the relative gene expression by running a dilution series of the ß globulin gene (LightCycler-Control Kit DNA; Roche Diagnostics GmbH) in each assay according to the manufacturer’s instructions.


View this table:
[in this window]
[in a new window]
 
Table 1. Sequences of Primers for 6 Selected Genes Studied in Real-time RT-PCR, and Comparison of Relative Gene Expression Levels in Real-time RT-PCR and cDNA Microarray from Five Ameloblastoma Patients
 

   RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Gene Expression Profile by cDNA Microarray
Thirty-four genes exhibited expression levels in at least 5 of 8 tumors (63%) that were different from those in the developing tooth germ (Table 2Go). Sixty genes were differentially expressed in at least 2 of the tumors (25%) when compared with respective normal control tissue (Fig. 1AGo). Eleven genes were overexpressed more than three-fold, and 23 genes were underexpressed to below 40% of the control level. The most highly overexpressed gene was FOS (from eight- to 14-fold, Fig. 2Go), followed by tumor-necrosis-factor-receptor 1 (TNFRSF1A). Genes for SHH, ARHGAP4, DCC (encoding mediators or receptors of cell signaling), CDH 12, and CDH 13 (encoding calcium-dependent cell-adhesion molecules), and TDGF1 and TGFB1 (encoding growth factors) were underexpressed in all cases (Fig. 1AGo).


View this table:
[in this window]
[in a new window]
 
Table 2. Differences in Gene Expression in at Least 5 of 8 (65%) Independent Microarray Hybridization Experiments Relating to Ameloblastoma
 



View larger version (54K):
[in this window]
[in a new window]
 
Figure 1. Gene expression profile in ameloblastoma. (A) Distribution of gene expression level in ameloblastoma by means of cDNA microarray visualized with TreeView. Ameloblastomas (from 1 to 8) are shown in columns, and genes are shown in rows. Genes showing differences in expression level are displayed in descending order, from underexpressed genes (green) to overexpressed genes (red). (B) Comparison of gene expression levels by means of scatterplot of log-intensities. Comparison between two normal tooth germ samples hybridized in separate experiments (i). Comparison between same ameloblastomas in separate experiments (ii), and between normal tooth germ and ameloblastoma (iii). Each point represents one of the 588 genes. X-axis represents gene expression level in one experiment. Y-axis represents gene expression level in second experiment. (C) Comparison between real-time RT-PCR and cDNA array results is plotted pairwise on successive rows for 6 genes in 5 ameloblastomas, respectively.

 


View larger version (42K):
[in this window]
[in a new window]
 
Figure 2. cDNA array images after hybridization of normal tooth germ (reference, R) and ameloblastomas (number of cases: from 1 to 8). Two genes are marked for visual identification in each experiment. Large arrows indicate a gene (FOS) overexpressed compared with reference (R); small arrows indicate a gene (ARHGAP4) underexpressed compared with reference (R).

 
Results obtained were reproducible when cDNA microarray hybridization experiments were repeated. Reproducibility was evaluated by means of XY scatterplots (Fig. 1BGo). R2 values can be considered as quantifying similarity between results of the experiments concerned. Two aliquots of pooled RNA derived from 20 tooth germs were used for control experiments. A very high R2 value of 0.986 was obtained. High degrees of similarity in relation to gene expression patterns were also found between tumor cases (R2 = 0.919).

Gene Expression by Image Analysis and XY Scatterplots
We obtained similar gene expression profiles using image analysis software (Clontech) with global normalization and XY scatterplots. These two methods identified 34 genes differentially expressed in most tumors (5 or more) in comparison with the reference. We also identified 60 differentially expressed genes in at least 2 tumors by means of global normalization analysis and 65 (the additional 5 being GIP3, DSC1, EFNB2, BMP5, and CDH6) by means of XY scatterplots (data not shown).

Gene Expression by Real-time RT-PCR
We compared relative gene expression change obtained by cDNA microarray with that by real-time RT-PCR methods to substantiate the reproducibility of our cDNA microarray results. The logarithm ratio between the gene expression levels of tumor samples and normal control tissue samples was calculated for 6 selected genes (Table 1Go). Genes for FOS, COL8A, and TNFRSF1A were found to be overexpressed and CDH11, SHH, and TGFB underexpressed by quantitative real-time RT-PCR in all 5 ameloblastomas studied (Fig. 1CGo). Although the degree of the relative gene expression change in the selected genes varied somewhat between the two methods used, we prefer to ascribe this to differences in sensitivity between the two methods. This is supported by the consequent pattern of lesser changes in the gene expression level detected in cDNA microarray compared with real-time RT-PCR (Fig. 1CGo).


   DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The genes identified in ameloblastoma by means of cDNA-microarray analysis include genes encoding transcription factors, growth factors and their receptors, and extracellular matrix (ECM) constituents. FOS was the most highly overexpressed gene (from eight- to 14-fold). Fos protein, encoded by proto-oncogene FOS, belongs to the AP-1 (activating protein-1) family of transcription factors that participate in the control of cell proliferation, cell differentiation, apoptosis, and oncogenic transformation (Sharma and Richards, 2000). Fos protein is important for bone development and is a key regulator of osteoclast-macrophage lineage determination and bone remodeling (Grigoriadis et al., 1994). Many cancers and neoplastic cells display FOS overexpression in vitro (Gamberi et al., 1998; Haufe et al., 2001), but the role of Fos protein in the pathogenesis of human tumors is not as yet clear.

The second most highly overexpressed gene was tumor-necrosis-factor-receptor 1A (TNFR1A), which is involved in the induction of AP-1 activity (for review, see Baud and Karin, 2001). Signal transduction is mediated by TNF-{alpha}, a potent cytokine produced by many cell types. It plays an important role in inflammation, and in control of cell proliferation, differentiation, and apoptosis. Recently, TNFs and their receptors have been shown to be involved in the development of ectodermally derived organs such as teeth (Laurikkala et al., 2001). Mutations in some TNF family members may result in human ectodermal dysplasia, causing abnormalities, e.g., in teeth (Monreal et al., 1999). Consequently, overexpression of FOS and TNFR1A may be important in the oncogenic transformation pathway of ameloblastoma.

Among the other overexpressed genes, it has been suggested that matrix metalloproteinases (MMPs), which degrade various ECM components, play important roles in organogenesis, tissue remodeling, and tumor invasion (Sato and Seiki, 1996; Ha et al., 2001). Overexpression of these genes has been reported in several malignancies, including hepatocellular carcinoma, colon carcinoma, and breast carcinoma (Gorrin Rivas et al., 1998; Jacobs et al., 1999). On the other hand, type-VIII collagen (encoded by COL8A) is an ECM protein anchored to the plasma membrane via a transmembrane segment. It has been suggested that it mediates cell adhesion (Shuttleworth, 1997). Distribution of type-VIII collagen in tissues is limited to endothelial cell-basement membranes. Overexpression of such a protein could have a bearing on processes involved in tumor angiogenesis.

Several genes in our study exhibited marked underexpression. A few of them also are known to be expressed aberrantly in other jaw diseases. Sonic hedgehog (SHH), which is expressed during early murine tooth development, is released by dental epithelium and induces expression of the transcription factor PTCH in mesenchyme (Hardcastle et al., 1998). It has been suggested that dysregulation of the PTCH/SHH signaling pathway in epithelial-mesenchymal interactions plays a role in the formation of odontogenic keratocysts (Lench et al., 1997; Barreto et al., 2000). This condition, although presumably not neoplastic, is clinically problematic because of its frequent recurrence, even after long symptom-free periods.

Many of the genes that were found to be underexpressed in the study reported here are involved in the regulation of cell adhesion, cell shape, and angiogenesis. For instance, CDHs, KRT7, NOTCH, and TGFB1 may be involved in disturbances of cell-to-cell adherence junctions and cell-to-cell communication (Pepper, 1997; Kawamura-Kodama et al., 1999; Pishvaian et al., 1999; Blobe et al., 2000; Bessho et al., 2001). This suggests that gap-junction communication may be low and cell adhesion lost in ameloblastomas, as described for many types of neoplasia. Such alterations in cell-membrane environment could also increase the locally aggressive growth potential of ameloblastomas.

Analyses of results of replicate experiments by two statistical methods gave essentially similar gene expression profiles. R2 values of over 90% were obtained, which suggested a satisfactory level of reproducibility. When results obtained by image analysis, global normalization, and XY scatterplots were compared, discrepancies were seen in relation to 5 genes. This level of discrepancy, relating to just 5 of the 588 genes (0.85%), was not considered significant, although any one of these genes could play an important role in connection with an individual tumor. Real-time PCR experiments gave similar relative gene expression changes, further supporting our microarray cDNA results. We also undertook cluster analysis as another means of assessing significances of differences relating to gene expression in each case and of relationships between cases. The results obtained reveal no association with known parameters, e.g., the histopathological pattern of the tumor. This finding corresponds to previous observations relating to ameloblastoma obtained by other methods (Melrose, 1999).

To conclude, we have demonstrated that several genes are over- or underexpressed in ameloblastoma compared with the tooth germ, its putative tissue of origin. Our findings provide a new basis for further studies intended to improve understanding of the molecular pathway of ameloblastoma development. These may reveal new targets relating to tumor diagnosis, prognosis, and intervention. In our study, several previously unidentified genes in the human tooth germ were also detected. These may be significant in relation to the regulation of normal tooth development.


   ACKNOWLEDGMENTS
 
The technical assistance of Ms. Merja Haukka, Ms. Ulla Kiiski, and Mr. Timo Kattelus is acknowledged. The work was supported financially by the Finnish Dental Society Apollonia and by the Maritza and Reino Salonen Foundation.


   FOOTNOTES
 
* contributed equally to the work; Back

Received August 27, 2001; Last revision March 25, 2002; Accepted May 13, 2002


   REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L (2000). PTCH gene mutations in odontogenic keratocysts. J Dent Res 79:1418–1422.[Abstract/Free Full Text]

Baud V, Karin M (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372–377.[Medline]

Bessho Y, Miyoshi G, Sakata R, Kageyama R (2001). Hes7: a bHLH-type repressor gene regulated by Notch and expressed in the presomitic mesoderm. Genes Cells 6:175–185.[Abstract]

Blobe GC, Schiemann WP, Lodish HF (2000). Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358.[Free Full Text]

Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM (1999). Expression profiling using cDNA microarrays. Nat Genet 21:10–14.[Medline]

Gamberi G, Benassi MS, Böhling T, Ragazzini P, Molendini L, Sollazzo MR, et al. (1998). C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 55:556–563.[Medline]

Gorrin Rivas MJ, Arii S, Furutani M, Harada T, Mizumoto M, Nishiyama H, et al. (1998). Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance. Hepatology 28:986–993.[Medline]

Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. (1994). C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443–448.[Abstract/Free Full Text]

Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, et al. (2001). Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 61:984–990.[Abstract/Free Full Text]

Hardcastle Z, Mo R, Hui CC, Sharpe PT (1998). The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants. Development 125:2803–2811.[Abstract]

Haufe CC, Eismann U, Deppisch RM, Stein G (2001). Expression of beta2-microglobulin and c-fos mRNAs: is there an influence of high-or low-flux dialyzer membranes ? Kidney Int 78(Suppl):177–181.

Heikinheimo K (1993). Cell growth and differentiation of developing and neoplastic odontogenic tissues (dissertation). Turku, Finland: Univ. of Turku.

Jääskeläinen K, Jee KJ, Leivo I, Saloniemi I, Knuutila S, Heikinheimo K (2002). Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet (in press).

Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ (1999). Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340:430–436.[Abstract/Free Full Text]

Jernvall J, Thesleff I (2000). Reiterative signaling and patterning during mammalian tooth morphogenesis. Mech Dev 92:19–29.[Medline]

Kawamura-Kodama K, Tsutsui J, Suzuki ST, Kanzaki T, Ozawa M (1999). N-cadherin expressed on malignant T cell lymphoma cells is functional, and promotes heterotypic adhesion between the lymphoma cells and mesenchymal cells expressing N-cadherin. J Invest Dermatol 112:62–66.[Medline]

Kramer IRH, Pindborg JJ, Shear M (1992). World Health Organization. International classification of tumours: histological typing of odontogenic tumors. 2nd ed. Heidelberg, Germany: Springer-Verlag.

Laurikkala J, Mikkola M, Mustonen T, Åberg T, Koppinen P, Pispa J, et al. (2001). TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis. Dev Biol 229:443–455.[Medline]

Lench NJ, Telford EA, High AS, Markham AF, Wicking C, Wainwright BJ (1997). Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Hum Genet 100:497–502.[Medline]

Melrose RJ (1999). Benign odontogenic tumors. Semin Diagn Pathol 16:271–287.[Medline]

Monreal AW, Ferguson BM, Headon DJ, Street SL, Overbeek PA, Zonana J (1999). Mutations in human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat Genet 22:366–369.[Medline]

Nieminen P, Pekkanen M, Åberg T, Thesleff I (1998). A graphical WWW-database on gene expression in tooth. Eur J Oral Sci 106(Suppl 1):7–11.

Pepper MS (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21–43.[Medline]

Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW (1999). Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59:947–952.[Abstract/Free Full Text]

Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. (2000). Systemic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227–235.[Medline]

Sato H, Seiki M (1996). Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119:209–215.[Abstract/Free Full Text]

Sharma SC, Richards JS (2000). Regulation of AP1 (Jun/Fos) factor expression and activation in ovarian granulosa cells. Relation of JunD and Fra2 to terminal differentiation. J Biol Chem 275:33718–33728.[Abstract/Free Full Text]

Shuttleworth CA (1997). Type VIII collagen. Int J Biochem Cell Biol 29:1145–1148.[Medline]

Todd R, Wong DT (2002). DNA hybridization arrays for gene expression analysis of human oral cancer. J Dent Res 81:89–97.[Abstract/Free Full Text]

Vickers RA, Gorlin RJ (1970). Ameloblastoma: delineation of early histopathologic features of neoplasia. Cancer 26:699–710.[Medline]




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
K. Heikinheimo, K.J. Jee, P.R. Morgan, B. Nagy, S. Knuutila, and I. Leivo
Genetic Changes in Sporadic Keratocystic Odontogenic Tumors (Odontogenic Keratocysts)
J. Dent. Res., June 1, 2007; 86(6): 544 - 549.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heikinheimo, K.
Right arrow Articles by Knuutila, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikinheimo, K.
Right arrow Articles by Knuutila, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)